Total Number Discharged – 154,325
Total Deaths – 2,061
Total Tests Carried out – 1,838,174
According to the NCDC, the 60 new cases are reported from 9 states- Lagos (22), Rivers (15), Bayelsa (7), Kaduna (5), Ogun (4), Akwa Ibom (3), Osun (2), Kano (1) and Ebonyi (1).
Meanwhile, the latest numbers bring Lagos state total confirmed cases to 58,110, followed by Abuja (19,756), Plateau (9,035), Kaduna (9,014), Rivers (7,060), Oyo (6,839), Edo (4,897), Ogun (4,639), Kano (3,942), Ondo (3,226), Kwara (3,120), Delta (2,617), Osun (2,572), Nasarawa (2,380), Enugu (2,281), Katsina (2,097), Gombe (2,034), Ebonyi (2,020), Anambra (1,909), Akwa Ibom (1,843), and Abia (1,683).
Imo State has recorded 1,655 cases, Bauchi (1,540), Borno (1,337), Benue (1,188), Adamawa (1,063), Niger (930), Taraba (910), Bayelsa (885), Ekiti (869), Sokoto (775), Jigawa (527), Kebbi (450), Cross River (394), Yobe (365), Zamfara (240), while Kogi state has recorded 5 cases only.
Lock Down and Curfew
In a
Total Number Discharged – 154,325
Total Deaths – 2,061
Total Tests Carried out – 1,838,174
According to the NCDC, the 60 new cases are reported from 9 states- Lagos (22), Rivers (15), Bayelsa (7), Kaduna (5), Ogun (4), Akwa Ibom (3), Osun (2), Kano (1) and Ebonyi (1).
Meanwhile, the latest numbers bring Lagos state total confirmed cases to 58,110, followed by Abuja (19,756), Plateau (9,035), Kaduna (9,014), Rivers (7,060), Oyo (6,839), Edo (4,897), Ogun (4,639), Kano (3,942), Ondo (3,226), Kwara (3,120), Delta (2,617), Osun (2,572), Nasarawa (2,380), Enugu (2,281), Katsina (2,097), Gombe (2,034), Ebonyi (2,020), Anambra (1,909), Akwa Ibom (1,843), and Abia (1,683).
Imo State has recorded 1,655 cases, Bauchi (1,540), Borno (1,337), Benue (1,188), Adamawa (1,063), Niger (930), Taraba (910), Bayelsa (885), Ekiti (869), Sokoto (775), Jigawa (527), Kebbi (450), Cross River (394), Yobe (365), Zamfara (240), while Kogi state has recorded 5 cases only.
Lock Down and Curfew
In a
British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.